This circRNA is associated with advanced clinical features, including larger tumor size, distant metastasis, and positive estrogen receptor (ER) and progesterone receptor (PR) status, underscoring its relevance in assessing disease progression and hormonal receptor status in BC [54]. This evidence concerns the gene ESR1 and breast cancer.